Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development
Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development
Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development
Submitted by
admin
on August 6, 2024 - 11:19am
Source:
PR Newswire
News Tags:
Shinobi
Japan
grants
cell therapy
Headline:
Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development
snippet:
Funds will support the development of Shinobi's lead iPS-T cell program targeting GPC3+ tumors.
Shinobi also expands its investor syndicate, with the addition of Yosemite and Mitsubishi UFJ Capital, bringing the company's total funding to $119M.
Do Not Allow Advertisers to Use My Personal information
